After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...